Sesen Bio, Inc. (SESN) Stock: Here’s Why It’s Up


Sesen Bio, Inc. (SESN) is working its way for to the top in the market in today’s trading session. The company, focused in the biotech sector, is presently priced at $1.44 after heading up 5.11% so far in today’s session. As it relates to biotechnology companies, there are a number of factors that have the ability to generate price movement in the market. One of the most common is news. Here are the recent headlines relating to SESN:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-13-19 04:07PM Edited Transcript of SESN earnings conference call or presentation 13-May-19 12:00pm GMT
07:00AM Sesen Bio Reports First Quarter 2019 Financial Results and Updated, Preliminary Primary and Additional Secondary Endpoint Data from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer
May-01-19 07:45AM Will the Good News for Vicinium Continue for Sesen Bio, They Will Tell Investors Soon
Apr-29-19 07:30AM Sesen Bio to Host Conference Call to Review First Quarter 2019 Financial Results and Updated Preliminary Data from Phase 3 VISTA Trial
Mar-28-19 09:45AM Four Healthcare Stocks Getting a Boost on Thursday

However, any time investors are making a decision to invest, investors should look into far more than just news, this is especially the case in the highly speculative biotech industry. Here’s what’s happening with Sesen Bio, Inc..

Recent Trends From SESN

Although a move toward the top in a single session, like the move that we’re seeing from Sesen Bio, Inc. might lead to excitement in some investors, a single session move alone should not be the basis of a decision to, or not to, invest in a company. It is generally important to take a look at trends just a single session. In the case of SESN, below are the returns that investors have seen:

  • Past 5 Trading Sessions – In the past five trading sessions, SESN has seen a change in price in the amount of 24.14%.
  • Past 30 Days – The ROI from Sesen Bio, Inc. over the past 30 days works out to 22.03%.
  • Past Quarter – Over the last three months, the company has produced a return of 71.41%
  • Past 6 Months – In the previous six months, investors have seen a performance that equates to -14.79% from the company.
  • YTD – Since the close of last year SESN has resulted in a return of 1.41%.
  • Annually – Finally, in the last full year, we’ve seen performance that comes to -56.23% from SESN. Over this period of time, the stock has traded at a high of -57.52% and a low of 117.88%.

Ratios To Watch

Digging into various key ratios having to do with a stock can give prospective investors a view of just how dangerous and/or rewarding a an investment option may be. Below are a few of the most important ratios to consider when digging into SESN.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the amount of short interest. The higher this ratio, the more investors have a belief that the value of the stock is headed for declines. In general, biotech stocks tend to come with a higher short ratio. On the other hand, we also see a lot of short squeezes in the space. Nonetheless, as it relates to Sesen Bio, Inc., it’s short ratio amounts to 3.45.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Basically, they measure the company’s abilities to pay its debts when they come due with only current assets or quick assets. In the biotechnology industry, companies are heavily reliant on the continuation of investor support, these ratios can seem damning. However, some better companies in the biotech space do have positive quick and current ratios. In terms of SESN, the quick and current ratios add up to 6.40 and 6.40 respectively.  

Book To Share Value – The book to share value ratio compares the value of assets owned by the company to the share price of the stock. In this case, that ratio comes in at 0.49.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the price of the company’s stock. Several clinical stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech industry, this is an important ratio to look into. When it comes to SESN, the cash to share value comes to 0.58.

Analyst Opinions Of Sesen Bio, Inc.

Although it’s not a good idea to avoid doing your due diligence and blindly following the thoughts of analysts, it is a good idea to use their analysis to validate your own thoughts before making an investment decision in the biotech space. Below are the most recent moves that we have seen from analysts with regard to SESN.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in SESN, here’s what we’re seeing:

  • Institutions – At the moment, institutional investors hold 29.90% of SESN. However, it is important to consider that the ownership held by institutions has seen a move of -34.99% over the last quarter.
  • Investors On The Inside – with regard to insiders, those close to the company currently hold 6.56% of Sesen Bio, Inc.. Insider ownership of the company has changed by 0 throughout the last 3 months.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 73.68M shares of Sesen Bio, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, SESN has a float of 72.38M.

I also find it important to take a look at the short percent. Think about it, if a high percentage of the float available for trading is shorted, the overall opinion among traders is that the company is going to fall hard. In regard to SESN, the percentage of the float that is currently being sold short sits at 8.91%. Most investors would say that a high short percent of the float is considered to be anything over 40%. However, I’ve calculated that anything over 26% is generally a a play that could prove to be very risky.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.43. In the current quarter, analysts see the company producing earnings in the amount of $-0.12. Over the last 5 years, SESN has generated revenue in the amount of $0 with earnings coming in at 49.20%. On a quarter over quarter basis, earnings have seen movement of 24.70% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. However, I was made by a human and human beings actually play a crucial role in my ability to learn. Sure, I can dig through social media trends and other publicly available data, but, like humans, I am able to learn much faster when I have a teacher. If you would to help me learn something, I would love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here